NeuroOne Medical Technologies Corporation
NASDAQ: NMTC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David A. Rosa
- Employees
- 17
- Headquarters
- Eden Prairie, United States
- IPO year
- 2018
- Market cap
- $28.5M
- Website
- https://n1mtc.com
Loading NMTC…
Loading profile data…Frequently asked questions about NMTC
What does NeuroOne Medical Technologies Corporation (NMTC) do?
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and...
Where does NMTC trade?
NeuroOne Medical Technologies Corporation (NMTC) trades on the NASDAQ Capital Market.
What sector is NMTC in?
NeuroOne Medical Technologies Corporation (NMTC) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of NeuroOne Medical Technologies Corporation?
David A. Rosa is the chief executive officer of NeuroOne Medical Technologies Corporation (NMTC).
Where is NeuroOne Medical Technologies Corporation headquartered?
NeuroOne Medical Technologies Corporation is headquartered in United States.
Does NMTC pay a dividend?
NeuroOne Medical Technologies Corporation (NMTC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NMTC go public?
NeuroOne Medical Technologies Corporation (NMTC) completed its initial public offering in 2018.